MOTS-c Peptide Therapy

MOTS-c Peptide Therapy involves the use of a mitochondria-derived peptide that plays a significant role in cellular energy metabolism and stress responses. This therapy is primarily aimed at individuals interested in exploring potential benefits for metabolic diseases, aging, and exercise performance. While promising in preclinical studies for improving insulin sensitivity and glucose tolerance, MOTS-c remains an investigational therapy with ongoing research required to establish its efficacy and safety.